Created at	Source	Raw Value	Validated value
June 23, 2022, 8:30 p.m.	usa	Immunogenicity of neutralizing antibody (GMT);Incidence of Adverse Event within 28 days post the second study intervention	Immunogenicity of neutralizing antibody (GMT);Incidence of Adverse Event within 28 days post the second study intervention